NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

RecruitingN/A

Sponsor: University Hospital Erlangen

Conditions: Polycystic Ovarian Syndrome (PCOS)

Countries: Germany

The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.

Eligibility overview

Sex: FEMALE

Age: 15 Years to 25 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Female subjects age 15-25 years
* Signed written informed consent

Exclusion Criteria:

* Less than 1 years from onset of menarche
* Use of hormonal contraceptives
* Documented ongoing pregnancy
* Major ovarian abnormalities, including subject with only one ovary, cysts and solid masses \> 2 cm as detected by transvaginal ultrasound
* Malignancy ( documented malignancy, documentation of current radiation therapy or chemotherapy in medical record)

Locations (1)

Erlangen, Germany